We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.35 | 29.50 | 29.95 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 172.65 | 158.53M |
TIDMAPH
RNS Number : 6116A
Alliance Pharma PLC
02 January 2018
ALLIANCE PHARMA PLC
("Alliance" or the "Group")
Block Listing Six Monthly Return
Name of applicant: ALLIANCE PHARMA PLC ----------------------------------------------------- --------------------------------------------------------------- Names of schemes: a) The Alliance Pharma plc Approved Share Option Plan 2005 b) The Alliance Pharma plc Share Option Plan 2006 c) The Alliance Pharma plc Company Share Option Plan 2015 ----------------------------------------------------- --------------------------------------------------------------- Period of return: From: 28 June 2017 To: 28 December 2017 ----------------------------- ---------------------- ----------------------- ------- ----------------------------- Number of securities originally admitted at date of 25,000,000 ordinary shares of 1p each admission: 28 June 2017 ----------------------------------------------------- --------------------------------------------------------------- Balance of unallotted securities under schemes from a) 2,248,922 previous return: b) 19,461,225 c) 3,289,853 ----------------------------------------------------- --------------------------------------------------------------- Plus: The amount by which the block schemes have a) Nil been increased since the date of the last b) Nil return (if any increase has been applied for): c) Nil ----------------------------------------------------- --------------------------------------------------------------- Less: Number of securities issued/allotted under a) 326,427 schemes during period: b) 355,982 c) Nil ----------------------------------------------------- --------------------------------------------------------------- Equals: Balance under schemes not yet a) 1,922,495 issued/allotted at end of period: b) 19,105,243 c) 3,289,853 ----------------------------------------------------- --------------------------------------------------------------- Name of contact: Marie-Claire Haines, Assistant Company Secretary ----------------------------- ------------------------------------------------- Telephone number of contact: Tel. +44 (0)1249 705166 ----------------------------- -------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRUKAURBKAUUAA
(END) Dow Jones Newswires
January 02, 2018 02:00 ET (07:00 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions